image

AbbVie, Inc. - Company Information

AbbVie, Inc. is a research-driven biopharmaceutical company that develops and markets advanced therapies for a wide range of medical conditions, inclu...Read more

Biotech & Pharmaceuticals
  • icon
    Headquarters

    North Chicago, Illinois, United States

  • icon
    Contact

    Unlock contact

  • icon
    Linkedin

    linkedin icon

  • icon
    Company Size

    10,000+

  • icon
    Stock Symbol

    ABBV

  • icon
    Website

    abbvie.com

  • icon
    Type

    Public

icon

AbbVie, Inc. Technology Stack

Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by AbbVie, Inc.

image

Microsoft BitLocker

thumbs_up

thumbs_down

BitLocker is a full disk encryption feature included with Windows Vista and later.

See more technologies

AbbVie, Inc. Employee Profiles

Are you looking for the decision-makers at AbbVie, Inc.? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover AbbVie, Inc.’s employee details in less than 30 secs.

Sign-up for 6sense Revenue AI™ for Sales

To find emails, direct dials, and more for prospects across the web.

Sign Up Today

AbbVie, Inc. Competitors

Discover AbbVie, Inc. alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.

image

OHMAN DESCALING SERVICES INC

  • icon
    Total Employees

    20 - 49

  • icon
    Location

    North Chicago

  • icon
    Website

    ohmandescaling.com

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

JENNIFER LYNN OLDEN

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    North Chicago

  • icon
    Website

    N/A

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Severstal PAO

  • icon
    Total Employees

    10,000+

  • icon
    Location

    Cherepovets

  • icon
    Website

    severstal.com

  • icon
    Type

    Public

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Huayu Automotive Systems Co Ltd

  • icon
    Total Employees

    10,000+

  • icon
    Location

    Shanghai

  • icon
    Website

    huayu-auto.com

  • icon
    Type

    Public

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

BanColombia S.A.

  • icon
    Total Employees

    10,000+

  • icon
    Location

    Medellin

  • icon
    Website

    bancolombia.com.co

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

Download the 6sense Chrome Extension to get verified contact data of AbbVie, Inc. employees

Install Now
Company Logo

AbbVie, Inc. News & Press Releases

Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are AbbVie, Inc. latest news, alerts and updates.

AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why

First, AbbVie completed the blockbuster $63 billion acquisition of Allergen in 2020. That brought commercial-stage drugs, like Botox and Juvederm, to AbbVie. It also brought knowledge from Allergen's long research and development (R&D) programs in aesthetics, neuroscience, and eye care.

Date Icon

26 Dec 2023

AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?

The pharma giant's latest big buyout offer is for Cerevel Therapeutics ( CERE 11.37%), a clinical-stage company developing treatments for schizophrenia and other neurological conditions. Despite not having any approved products to sell yet, AbbVie offered Cerevel $8.7 billion in cash, or $45 per share.

Date Icon

8 Dec 2023

AbbVie to Acquire Cerevel for $8.7B, Growing Neuro Drug Pipeline

AbbVie has agreed to acquire Cerevel Therapeutics for $8.7 billion, in a deal designed to expand the buyer's pipeline with Cerevel's neuroscience and psychiatric drug candidates.

Date Icon

7 Dec 2023

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.

Date Icon

6 Dec 2023

AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion

AbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify its oncology pipeline across solid tumors and hematologic malignancies.

Date Icon

1 Dec 2023

AbbVie strikes deal to acquire Waltham's ImmunoGen for more than $10 billion

Pharmaceutical giant AbbVie said Thursday it has agreed to pay more than $10 billion to buy Waltham cancer drug maker ImmunoGen, in the largest acquisition of a Massachusetts company this year.

Date Icon

30 Nov 2023

FAQs for AbbVie, Inc.

Explore frequently asked questions about AbbVie, Inc.’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.

What is AbbVie, Inc.'s official website?

The official website of AbbVie, Inc. is abbvie.com You can find their contact number, email address, and headquarters by clicking here.

faq icon

How many employees are working at AbbVie, Inc.?

faq icon

What industry is AbbVie, Inc. in?

faq icon

What is AbbVie, Inc.'s tech stack?

faq icon

Where are AbbVie, Inc.'s headquarters?

faq icon

Get instant access to B2B contact data across the web

Sign Up Today
6sense Logo
social iconssocial iconssocial iconssocial icons
MarketingAccount IdentificationIntent DataData Enrichment & ManagementPredictive AnalyticsOrchestrations & WorkflowsAudience BuildingAdvertisingConversational EmailPipeline IntelligenceIntegrations
SolutionsBusiness ServicesFinancial ServicesTransportation & LogisticsManufacturingTechnologyCustomersMeet Our CustomersCustomer StoriesCustomer ReviewsRevCityKnowledge Base

Company

AboutLeadership TeamCareersNewsroomCommunity

Browse 6sense Data

TechnographicsComparing TechnologiesCompany SearchPeople Search
TermsPrivacy PolicyPrivacy CenterDo Not Sell or Share My Personal Information

© 2024 6sense